Pages Tagged with "Zen Logsdon"
Discovery could lead to new treatments for blood cancer patients currently facing limited optionsCONTACTZen [email protected]
LOS ANGELES — Scientists at City of Hope®, one...
The bidirectional research looks at both laboratory and human clinical trial data, finding that medicinal use of white button mushroom reduces the type of cells that weaken the immune system...
The comprehensive cancer center’s experts will spotlight scientific data on how dietary choices, psychosocial support, massage therapy and mind-body calming practices can improve outcomes and the quality of life of...
Highlights include a late-breaking oral abstract that is part of ASTRO’s press program, theranostics (therapy and diagnostics), and use of artificial intelligence to evaluate cancer patients’ immune response to radiotherapy...
The prize, one of the largest privately funded awards for scientific investigation, will be given to the world’s top researchers, regardless of institutional affiliation LOS ANGELES — City of...
•Researchers will evaluate whether the cannabinoid therapeutic candidate can address joint pain resulting from cancer treatment using aromatase inhibitors •This side effect has caused many breast cancer patients to discontinue...
People in the Philippines can now receive leading-edge, clinical care recommendations from City of Hope cancer specialists CONTACTZen [email protected] LOS ANGELES — Oncology specialists...
Nationally renowned scientist honored for unlocking genomic factors behind inequitable cancer rates for prostate, breast and other cancers CONTACTZen [email protected]
LOS ANGELES — John D. Carpten...
City of Hope developed a novel use of biotherapeutic product CBM588 in the treatment of cancer; new research suggests the agent adjusts people’s microbiome, possibly leading to enhanced effectiveness of...
Readmission rate of open liver surgery is 20-25% at most major cancer centers, yet the readmission rate for robotic hepatectomy was 1.6% in this retrospective analysis of data from six...